Michael Pratta
14Patents
4h-index
26Co-inventors
60Inventor score
Filing activity: Jul 24, 1998 → May 20, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9090694B2 | ST2L antibody antagonists | Chemistry; Metallurgy | 18 | Active |
| US9212227B2 | ST2L antibody antagonists for the treatment of ST2L-mediated inflammatory pulmonary conditions | Chemistry; Metallurgy | 12 | Active |
| US6451575B1 | Aggrecan degrading metallo proteases | Physics | 8 | Expired |
| US6326162A | Assays and peptide substrate for determining aggrecan degrading metallo protease activity | Physics | 6 | Expired |
| US11372003B2 | Biomarkers for graft-versus-host disease | Physics | 3 | Active |
| US7223834B2 | Assays and peptide substrate for determining aggrecan degrading metallo protease activity | Physics | 2 | Expired |
| US9951137B2 | ST2L antagonists and methods of use | Chemistry; Metallurgy | 2 | Active |
| US6521436B1 | Nucleic acids encoding aggrecan degrading metallo proteases | Physics | 2 | Expired |
| US7049412B1 | Antibodies to aggrecan-degrading metalloprotease and diagnostic methods using same | Physics | 2 | Expired |
| US10450377B2 | ST2L antagonists and methods of use | Chemistry; Metallurgy | 1 | Active |
| US12099068B2 | Biomarkers for graft-versus-host disease | Physics | 0 | Active |
| US6753176B2 | Aggrecan degrading metallo proteases | Physics | 0 | Expired |
| US12203942B2 | Biomarkers for graft-versus-host disease | Physics | 0 | Active |
| US12360120B2 | Biomarkers for graft-versus-host disease | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.